Keyword Suggestion
Domain Informations
Fulphila.com lookup results from whois.markmonitor.com server:
- Domain created: 2016-04-13T20:20:53Z
- Domain updated: 2023-08-31T05:19:46Z
- Domain expires: 2025-04-13T20:20:53Z 0 Years, 197 Days left
- Website age: 8 Years, 167 Days
- Registrar Domain ID: 2021451727_DOMAIN_COM-VRSN
- Registrar Url: http://www.markmonitor.com
- Registrar WHOIS Server: whois.markmonitor.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.2086851750
- Name server:
- NS1.MARKMONITOR.COM
- NS2.MARKMONITOR.COM
- NS3.MARKMONITOR.COM
- NS4.MARKMONITOR.COM
- NS5.MARKMONITOR.COM
- NS6.MARKMONITOR.COM
- NS7.MARKMONITOR.COM
Network
- inetnum : 20.33.0.0 - 20.128.255.255
- name : MSFT
- handle : NET-20-33-0-0-1
- status : Direct Allocation
- created : 1998-07-10
- changed : 2024-03-18
- desc : To report suspected security issues specific to traffic emanating from Microsoft online services, including the distribution of malicious content or other illicit or illegal material through a Microsoft online service, please submit reports to:,* https://cert.microsoft.com.,For SPAM and other abuse issues, such as Microsoft Accounts, please contact:,* [email protected].,To report security vulnerabilities in Microsoft products and services, please contact:,* [email protected].,For legal and law enforcement-related requests, please contact:,* [email protected],For routing, peering or DNS issues, please,contact:,* [email protected]
Owner
- organization : Microsoft Corporation
- handle : MSFT
- address : Array,Redmond,WA,98052,US
Technical support
- handle : IPHOS5-ARIN
- name : IPHostmaster, IPHostmaster
- phone : +1-425-538-6637
- email : [email protected]
Abuse
- handle : MAC74-ARIN
- name : Microsoft Abuse Contact
- phone : +1-425-882-8080
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 20.119.128.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 20.119.128.11)
Spam Check (IP: 20.119.128.11)
Recent Searched Sites
› Kaspawallet.net (13 seconds ago) / US
› Mobile.rai.it (18 seconds ago) / US
› Aumalverntc.sales.ticketsearch.com (3 seconds ago) / US
› Trustorg.com (16 seconds ago) / US
› Srlm.org (3 seconds ago) / US
› Violifefoods.com (34 seconds ago) / US
› Rzxgamer.com (10 seconds ago) / UA
› Pacificindustrialwater.com (40 seconds ago) /
› 051311.com (4 seconds ago) / CA
› Static.rfi.fr (6 seconds ago) / US
› Fulphila.com (0 seconds ago) / US
› Rte.mx (12 seconds ago) / US
› Dresden.gold (12 seconds ago) / DE
› Cawmansmall.com (17 seconds ago) / US
› I-trekkings.net (21 seconds ago) / FR
› Ramshaw.com (1 seconds ago) / US
› Gowish.com (40 seconds ago) /
› Worok.com (13 seconds ago) / US
› Citibank.co.kr (48 seconds ago) / US
› Visamanglobalsales.com (50 seconds ago) /
Websites Listing
We found Websites Listing below when search with fulphila.com on Search Engine
Fulphila® (pegfilgrastim-jmdb) | Official website for HCPs
Fulphila is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. IMPORTANT SAFETY INFORMATION. Do not administer Fulphila to patients with a history of serious allergic reactions, including anaphylaxis, to pegfilgrastim or filgrastim. Splenic rupture, including fatal cases, can occur following the administration of …
Fulphila.comFulphila® (pegfilgrastim-jmdb) | Patient Access Support ...
Fulphila is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. IMPORTANT SAFETY INFORMATION. Do not administer Fulphila to patients with a history of serious allergic reactions, including anaphylaxis, to pegfilgrastim or filgrastim. Splenic rupture, including fatal cases, can occur following the administration of …
Fulphila.comFulphila®
Fulphila®. Please select from the options below in order to enter this site. I am a health care professional. I have been prescribed Fulphila®. ×. This website is intended for Canadian Healthcare professionals only. Please enter your medical license number below. Select Province Alberta Manitoba Newfoundland Labrador British Columbia New ...
Fulphila.caFulphila® (pegfilgrastim-jmdb) | Co-Pay Patient Access for ...
Fulphila is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. IMPORTANT SAFETY INFORMATION. Do not administer Fulphila to patients with a history of serious allergic reactions, including anaphylaxis, to pegfilgrastim or filgrastim. Splenic rupture, including fatal cases, can occur following the administration of …
Fulphila.comFulphila
In order to improve its emails, websites and information services, Viatris may track whether I received an email, opened it, clicked on any links, viewed or downloaded any documents within it. I understand that my consent is voluntary and I can withdraw my consent at any time. The withdrawal of consent will not affect the lawfulness of processing based on consent before its …
Fulphila-my.comFulphila®
Postal Code **. Phone Number **. Email Address **
Fulphila.caPatient Information Leaflet - Fulphila
Information about Fulphila that is written for health professionals. What are the ingredients in Fulphila? Active ingredient: pegfilgrastim-jmdb. Inactive ingredients: acetate, D-sorbitol, polysorbate 20, and sodium in Water for Injection. Please see accompanying Full Prescribing Information. Title : Fulphila_Patient Brochure_Nov2019_OpenFile_Artwork Created Date: …
Fulphila.comFulphila® (pegfilgrastim-jmdb) | for HCPs
Fulphila is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. IMPORTANT SAFETY INFORMATION. Do not administer Fulphila to patients with a history of serious allergic reactions, including anaphylaxis, to pegfilgrastim or filgrastim. Splenic rupture, including fatal cases, can occur following the administration of …
Fulphila.comNON-2019-1600 Portal User Guide DIGITAL
See the email, check your email spam folder. Users will have 48 hours to utilize the temporary password provided in the email. If the temporary password has expired, call Viatris Advocate at 1(833) 695-2623 to request a new one. Registering for Viatris Advocate Portal Access STEP 4: Enter the account details and click “Continue.” Establishing Site and Provider Af˜ liations 1 2 …
Viatrisadvocate.comViatris Advocate Portal
Fulphila and Ogivri have not been approved by FDA for concomitant use
Viatrisadvocateportal.comMEDICARE FORM Pegfilgrastim Precertification Request ...
(Fulphila®, Neulasta®, Neulasta Onpro®, Nyvepria®, Udenyca®, Ziextenzo®) For Medicare Advantage Part B: FAX: 1-844-268-7263 . PHONE: 1-866-503-0857 . For other lines of business: Please use other form. Note: Fulphila, Nyvepria and Ziextenzo are non-preferred. Neulasta/Neulasta Onpro and Udenyca are preferred.
Aetna.comFulphil
“Fulphil is setting new standards for nurturing the entrepreneurial mindsets of [youth] and has built a differentiated instructional model that drives critical thinking and real-world problem-solving skills for the students they serve.”
Fulphil.orgfulphila Coupons and Discount Cards - rxless
EMAIL: [email protected] New Search. fulphila discount cards. Generic: Pegfilgrastim (E. coli) Brand: Fulphila. What is fulphila? PEGFILGRASTIM (PEG fil gra stim) is a long-acting granulocyte colony-stimulating factor that stimulates the growth of neutrophils, a type of white blood cell important in the body's fight against infection. It is used to reduce the incidence of …
Rxless.com3U )XOSKLOD - Mylan
)xosklod 3djh ri '26$*( $1' $'0,1,675$7,21 'rvlqj &rqvlghudwlrqv )xosklod shjilojudvwlp vkrxog eh dgplqlvwhuhg qr vrrqhu wkdq krxuv diwhu wkh dgplqlvwudwlrq
Mylan.caPegfilgrastim Precertification Request Aetna ...
, Fulphila ®, Nyvepria. TM, Udenyca ®, Ziextenzo ®) Page 1 of 2 . Aetna Precertification Notification . Phone: 1-866-752-7021. FAX: 1-888-267-3277 . For Medicare Advantage Part B: Please Use Medicare Request Form (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start date / /
Aetna.comFulphila Injection - FDA prescribing information, side ...
2021-10-01 · Fulphila is a clear, colorless, preservative-free solution available as: • Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only. Contraindications. Fulphila is contraindicated in patients with a history of serious allergic reactions to pegfilgrastim products or filgrastim products.
Drugs.comFULPHILA 6 mg sol inj en seringue préremplie - VIDAL
2022-02-17 · FULPHILA 6 mg S inj en seringue préremplie Ser sécur. Cip : 3400930163245. Liste 1. Agréé aux Collectivités. Remboursement : 100%. Commercialisé.
Vidal.frFulphila (Pegfilgrastim-jmdb Injection, for Subcutaneous ...
2021-04-26 · Fulphila is provided in a dispensing pack containing one sterile 6 mg/0.6 mL prefilled syringe. NDC 67457-833-06. Fulphila prefilled syringe does not bear graduation marks and is intended only to deliver the entire contents of the syringe (6 mg/0.6 mL) for direct administration. Use of the prefilled syringe is not recommended for direct administration for …
Rxlist.comFulphila - hpra.ie
If you have any queries about specific SPCs on our website then please e-mail [email protected]. Fulphila. Viatris Limited EU/1/18/1329/001-002. Main Information. Trade Name Fulphila. Active Substances Pegfilgrastim. Dosage Form Solution for injection in pre-filled syringe. Licence Holder Viatris Limited. Licence Number EU/1/18/1329/001-002. Group Information. ATC Code …
Hpra.ieMylan’s Fulphila: First Neulasta Biosimilar’s Road To US ...
Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: Mylan’s Fulphila: First Neulasta Biosimilar’s Road To US Market Slowed Only By Product Quality, GMP Deficiencies Add a personalized message to your email. Cancel. Send. Please Note: Only individuals with an active subscription will be …
Generics.pharmaintelligence.informa.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
pennthorpe.com | enomdomains.com | -1 Years, -217 Days |
estatemakati.com | publicdomainregistry.com | -1 Years, -355 Days |
valsparcolorverse.com | cloudflare.com | -2 Years, -30 Days |
vanessagloordds.com | register.com | -2 Years, -155 Days |
gripmedia.com | tucows.com | -1 Years, -334 Days |
aaafpark.com | publicdomainregistry.com | -2 Years, -177 Days |
tootikhabar.com | joker.com | -1 Years, -265 Days |
fmenews.com | namecheap.com | -2 Years, -139 Days |
gai4.com | namesilo.com | -1 Years, -317 Days |
onlinecasinostar7.com | epik.com | -2 Years, -105 Days |